Lilly’s Alzheimer’s Data for Donanemab

Link. “We will eventually find out if these drugs can actually help patients in the real world, or whether they do more harm than (any) good. In a more rational world, we might try finding all this out before we approve them and sell them to patients, but we’re clearly going to do it the other way.”

Britain’s NHS goes from bad to worse.

Link. The article describes neither cause nor fix; Canada and the US have less severe but similar issues. I think it’s a combination of demographics, Baumol’s Cost Disease, the complexity of modern medicine, and the failure of medical informatics to deliver on its promises.

Claude.ai

Link. “Anthropic’s new Claude 2 model is available to use online, and it has a 100k token context window and the ability to upload files to it”